In addition, IMD-4690 strongly inhibited airway remodeling by regulating the production of remodeling-related mediators (i.e., TGF-β, VEGF, and HGF) and enzymes (i.e., MMP9) in a chronic antigen exposure mouse model of asthma with Dp. Here, MMP9 is linked to asthma.